Publications (87) NURIA MUÑOZ RIVAS publications

filter_list

2025

  1. Anticoagulation Among Patients Hospitalized for COVID-19 A Systematic Review and Prospective Meta-analysis

    Annals of Internal Medicine, Vol. 178, Núm. 1, pp. 59-69

  2. Development of a Predictive Model of Occult Cancer After a Venous Thromboembolism Event Using Machine Learning: The CLOVER Study

    Medicina (Lithuania), Vol. 61, Núm. 1

  3. Diagnosis and treatment of pulmonary embolism. Recommendations of the Thromboembolic Disease Group of the Spanish Society of Internal Medicine 2024

    Revista Clinica Espanola, Vol. 225, Núm. 3, pp. 168-175

  4. Position paper on the 2024 ESH clinical practice guidelines for the management of arterial hypertension in Spain

    Hipertensión y riesgo vascular, Vol. 42, Núm. 1, pp. 52-58

  5. Positioning for the use of multivessel clinical ultrasound in vascular risk evaluation: VASUS+ protocol. 2024 recommendations of the vascular risk group, clinical ultrasound of the Spanish Society of Internal Medicine and Spanish Society of Hypertension and Vascular Risk

    Revista Clinica Espanola, Vol. 225, Núm. 4, pp. 223-230

2024

  1. Diagnosis and treatment of deep vein thrombosis of the lower and upper limbs. 2024 recommendations of the thromboembolic disease group of the Spanish Society of Internal Medicine

    Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 300-313

  2. External validation of the CHEDDAR score for suspected pulmonary embolism in patients with SARS-CoV-2 infection in an independent cohort

    Journal of Thrombosis and Thrombolysis, Vol. 57, Núm. 3, pp. 352-357

  3. External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study

    Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2685-2692

  4. Low Muscle Strength Assessed with Dynamometry in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry

    Journal of Clinical Medicine, Vol. 13, Núm. 16

  5. Position paper on retinal arterial occlusion. SEMI-SERV

    Revista Clinica Espanola, Vol. 224, Núm. 9, pp. 588-597

  6. Systematic review of clinical trials on the antithrombotic therapy with factor XI inhibitors

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 167-177

2023

  1. Acute phase characteristics and long-term complications of pulmonary embolism in COVID-19 compared to non-COVID-19 cohort: a large single-centre study

    BMC pulmonary medicine, Vol. 23, Núm. 1, pp. 25

  2. Artificial intelligence for recurrence in patients with venous thromboembolism: towards a new era

    Revista clinica espanola

  3. Clinical Characteristics and Prognostic Impact of Short Physical Performance Battery in Hospitalized Patients with Acute Heart Failure—Results of the PROFUND-IC Registry †

    Journal of Clinical Medicine, Vol. 12, Núm. 18

  4. Consensus document of the Spanish Society of Obstetrics and Gynecology (SEGO) and the Spanish Interdisciplinary Committee for Vascular Prevention (CEIPV). Opportunity window: vascular risk prevention in women. Adverse pregnancy outcomes and risk of vascular disease

    Revista espanola de salud publica, Vol. 97

  5. Consensus document of the Spanish Society of Obstetrics and Gynecology (SEGO) and the Spanish Interdisciplinary Committee for Vascular Prevention (CEIPV). Opportunity window: vascular risk prevention in women. Adverse pregnancy outcomes and risk of vascular disease.

    Revista Espanola de Salud Publica, Vol. 97

  6. Prediction of Venous Thromboembolism in Patients With Cancer Using Machine Learning Approaches: A Systematic Review and Meta-Analysis

    JCO clinical cancer informatics, Vol. 7, pp. e2300060

  7. Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: A systematic review

    Revista Clinica Espanola, Vol. 223, Núm. 1, pp. 40-49

2022

  1. Clinical Characteristics, Management, and In-Hospital Mortality in Patients with Heart Failure with Reduced Ejection Fraction According to Sex and the Presence of Type 2 Diabetes Mellitus

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

    Journal of Clinical Medicine, Vol. 11, Núm. 19